V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 90008284 | 90005589 | null | 74 | Adjuvant (A) | 2006-09-05 | 2017-09-01 | Pemetrexed | N | N | 90041564 | CETUXIMAB + IRINOTECAN + MDG |
| 90005249 | 90002739 | 1.72 | 102 | Palliative (P) | 2012-09-10 | 2017-08-31 | Trial Unspecified | N | N | 90041564 | EVEROLIMUS |
| 90005877 | 90003045 | null | 93.4 | Palliative (P) | 2017-07-16 | 2017-07-16 | GemCarbo Days 1+8 | 02 | N | 90041563 | ETOPOSIDE |
| 90008283 | 90005588 | 1.8 | 81 | Palliative (P) | 2015-04-05 | 2015-09-29 | WT Guidelines Carboplatin/Etoposide | N | N | 90041538 | CVD |
| 90010551 | 90005587 | null | 81.4 | Palliative (P) | null | 2018-01-28 | Cisplatin + Etoposide + RT | 02 | N | 90041509 | ICE-R |
| 90005242 | 90002738 | null | 51.6 | Curative (C) | 2015-06-18 | 2015-07-10 | Trial Unspecified | N | N | 90041486 | BORTEZOMIB |
| 90005248 | 90002738 | null | 69 | Palliative (P) | 2017-06-28 | 2017-07-01 | Trial Unspecified | null | N | 90041486 | STAR TRIAL |
| 90005247 | 90002738 | 1.7 | 17.45 | Curative (C) | 2015-09-10 | 2015-09-22 | WT Relapsed UKWR, Group A, VA | N | N | 90041486 | NOT MATCHED |
| 90005246 | 90002738 | 1.57 | 84 | Curative (C) | 2014-01-12 | 2014-01-26 | Trial Unspecified | N | N | 90041486 | CISPLATIN + GEMCITABINE |
| 90005243 | 90002738 | 1.7 | null | Palliative (P) | 2015-06-28 | 2015-07-06 | Temsirolimus weekly | N | N | 90041486 | TRIAL |
| 90005244 | 90002738 | null | 65 | Palliative (P) | 2017-04-17 | 2017-04-22 | Doxorubicin 75mg/m2 | 1 | N | 90041486 | TRIAL |
| 90005245 | 90002738 | null | 86.4 | Palliative (P) | 2015-05-24 | 2015-05-24 | Trial Unspecified | Y | N | 90041486 | CISPLATIN + DOXORUBICIN + ETOPOSIDE |
| 90008280 | 90008446 | 0 | 0 | Adjuvant (A) | 2017-07-12 | 2017-07-12 | STAR TRIAL | N | N | 90041483 | STAR TRIAL |
| 90009815 | 90008446 | 1.74 | 0 | Palliative (P) | 2018-03-24 | 2018-03-24 | ZEBRA TRIAL | 1 | N | 90041483 | OXALIPLATIN + MDG |
| 90010550 | 90008446 | 1.74 | null | Palliative (P) | 2018-08-25 | 2018-09-01 | Capecitabine | N | N | 90041483 | CISPLATIN + VINORELBINE |
| 90008282 | 90008446 | null | 89 | Palliative (P) | 2017-07-22 | 2017-07-22 | Carboplatin + Paclitaxel (3 weekly) | null | null | 90041483 | RUXOLITINIB |
| 90008281 | 90008446 | null | null | Palliative (P) | 2015-06-26 | 2015-07-10 | WT2001 | N | null | 90041483 | FEC + DOCETAXEL |
| 90009816 | 90008446 | null | null | Palliative (P) | 2017-11-25 | 2017-12-09 | Bevacizumab 15mg/kg | N | N | 90041483 | VINCRISTINE |
| 90005240 | 90002737 | 1.55 | 84.4 | Palliative (P) | 2016-10-27 | 2016-11-01 | TOUCAN TRIAL | N | N | 90041481 | TRIAL |
| 90005241 | 90002737 | 1.68 | 69.5 | Palliative (P) | 2017-07-12 | 2017-07-12 | CARBOPLATIN + ETOPOSIDE | 02 | N | 90041481 | GEMCARBO |
| 90008279 | 90005586 | null | 55.9 | Adjuvant (A) | 2016-09-05 | 2017-05-08 | Everolimus 10mg | N | N | 90041481 | EVEROLIMUS |
| 90009814 | 90005585 | null | null | Adjuvant (A) | 2016-11-12 | 2016-12-18 | WT Guidelines Carboplatin/Etoposide | N | N | 90041471 | GEMCARBO |
| 90008278 | 90005585 | 1.78 | 64 | Neo-adjuvant (N) | 2016-09-25 | 2016-09-25 | EVEROLIMUS | 2 | N | 90041471 | PACLITAXEL |
| 90005237 | 90002736 | null | 17.4 | Palliative (P) | 2018-05-29 | 2018-06-06 | Imatinib 400mg | Y | N | 90041448 | STAR TRIAL |
| 90005236 | 90002736 | null | 87.65 | Neo-adjuvant (N) | 2016-01-17 | 2016-01-21 | NIVOLUMAB | 2 | N | 90041448 | CAPECITABINE |
| 90005238 | 90002736 | 1.78 | 60.4 | Palliative (P) | 2016-12-26 | 2017-01-01 | Carboplatin + Etoposide iv&po | N | N | 90041448 | TRIAL |
| 90005239 | 90002736 | 1.7 | null | Palliative (P) | 2016-08-21 | 2016-09-25 | CTD | Y | N | 90041448 | BORTEZOMIB + PANOBINOSTAT |
| 90005235 | 90002735 | 1.8 | null | Curative (C) | 2014-04-20 | 2014-04-20 | Bortezomib + Cyclophos + Dex | 01 | N | 90041447 | R-EPOCH |
| 90008277 | 90009896 | 1.59 | 113.5 | Palliative (P) | 2014-09-13 | 2014-09-13 | Trastuzumab Subcutaneous | N | N | 90041447 | TRASTUZUMAB |
| 90008276 | 90005584 | 1.52 | 79.3 | Palliative (P) | 2017-12-07 | 2017-12-16 | PACLITAXEL | N | null | 90041431 | EVEROLIMUS |
| 90009813 | 90005584 | null | 102 | Curative (C) | 2017-09-02 | 2018-02-25 | Azacitidine | N | N | 90041431 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 90008275 | 90005583 | 1.88 | 65.1 | Palliative (P) | 2017-08-27 | 2017-08-27 | STAR TRIAL | N | N | 90041431 | CISPLATIN + GEMCITABINE |
| 90008274 | 90005580 | 1.8 | 89 | Palliative (P) | 2017-06-15 | 2017-06-27 | FLUOROURACIL + OXALIPLATIN | N | N | 90041421 | EVEROLIMUS |
| 90010549 | 90005582 | null | 70 | Palliative (P) | 2018-11-05 | 2018-11-14 | STAR TRIAL | N | N | 90041421 | EOX |
| 90005231 | 90002734 | null | 89.3 | Palliative (P) | null | 2017-06-27 | NIVOLUMAB | N | N | 90041421 | CARBOPLATIN + PACLITAXEL |
| 90005232 | 90002734 | 1.63 | 77.2 | Palliative (P) | 2017-08-20 | 2017-08-20 | Paclitaxel 7 day | N | N | 90041421 | GEMCARBO |
| 90005233 | 90002734 | 1.79 | 102 | Neo-adjuvant (N) | 2016-03-19 | 2016-04-08 | Bortezomib + Cyclophos + Dex | N | N | 90041421 | MPV |
| 90009812 | 90005581 | null | 50.55 | Palliative (P) | 2018-08-15 | 2018-08-15 | Azacitidine | 02 | N | 90041421 | AZACITIDINE |
| 90005234 | 90002734 | null | 70 | Neo-adjuvant (N) | 2017-10-15 | 2017-11-25 | EW EuroEwing 2012 Arm B VDC | Y | N | 90041421 | TEMOZOLOMIDE + RT |
| 90008273 | 90005578 | 1.8 | 66.9 | Palliative (P) | 2018-02-22 | 2018-02-22 | Everolimus 10mg | N | N | 90041418 | GEMCARBO |
| 90010898 | 90005579 | null | 54.8 | Palliative (P) | 2019-10-03 | 2019-10-03 | EVEROLIMUS | N | N | 90041418 | CISPLATIN + GEMCITABINE |
| 90005230 | 90002733 | null | 20.7 | Adjuvant (A) | null | 2017-09-14 | Trial Unspecified | 2 | null | 90041418 | HYDROXYCARBAMIDE |
| 90009811 | 90005578 | 1.63 | null | Palliative (P) | null | 2018-12-02 | Everolimus 10mg | N | N | 90041418 | POMALIDOMIDE |
| 90010548 | 90005579 | 0 | 80 | Palliative (P) | 2019-05-08 | 2019-05-15 | EVEROLIMUS | N | N | 90041418 | EVEROLIMUS |
| 90008272 | 90005576 | 1.83 | 67.2 | Palliative (P) | 2015-03-18 | 2015-03-25 | Everolimus 10mg | N | N | 90041409 | EVEROLIMUS |
| 90009810 | 90005577 | 1.7 | 96.1 | Adjuvant (A) | 2016-05-10 | 2016-06-12 | STAR TRIAL | N | N | 90041409 | IRINOTECAN + MDG |
| 90005229 | 90002732 | 1.54 | 47.7 | Palliative (P) | 2013-10-27 | 2013-10-27 | BEP 3 day | Y | N | 90041409 | NIVOLUMAB |
| 90005228 | 90002731 | 1.68 | -1 | Disease modification (D) | 2015-07-03 | 2015-10-15 | CABOZANTINIB | N | N | 90041401 | TRIAL |
| 90005227 | 90007105 | 0 | 70.2 | Palliative (P) | 2015-04-20 | 2015-04-20 | Hydroxycarbamide | Y | null | 90041397 | TRIAL |
| 90005226 | 90002730 | 1.59 | 13.1 | Curative (C) | 2015-01-18 | 2015-01-18 | Trial Unspecified | N | N | 90041382 | TRIAL |